hVIVO

FY2024 trading update and acquisition announced

  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 20.4p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

Person's Name

Colin Grant

Analyst

DAVY VIEW

2024 was a record year for hVIVO with stronger-than-expected top line growth and margin expansion. It moved into its new world leading facility, adding scale, and it launched new services. It has announced a strategic acquisition in Germany that will be integrated in 2025 and will provide opportunities in 2026.

View full article

Download full report with analyst certification and important disclosures

Jan 29 2025, 07:10 GMT

Download